Walker Asset Management LLC Has $430,000 Stock Position in Danaher Co. (NYSE:DHR)

Walker Asset Management LLC reduced its position in shares of Danaher Co. (NYSE:DHR) by 6.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,546 shares of the conglomerate’s stock after selling 100 shares during the period. Walker Asset Management LLC’s holdings in Danaher were worth $430,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in DHR. AdvisorNet Financial Inc grew its stake in shares of Danaher by 11.3% during the first quarter. AdvisorNet Financial Inc now owns 758 shares of the conglomerate’s stock worth $189,000 after buying an additional 77 shares during the last quarter. Dynamic Advisor Solutions LLC grew its stake in shares of Danaher by 8.3% during the first quarter. Dynamic Advisor Solutions LLC now owns 7,744 shares of the conglomerate’s stock worth $1,934,000 after buying an additional 591 shares during the last quarter. Procyon Advisors LLC grew its stake in shares of Danaher by 14.0% during the first quarter. Procyon Advisors LLC now owns 8,789 shares of the conglomerate’s stock worth $2,195,000 after buying an additional 1,082 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of Danaher by 3.8% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 194,515 shares of the conglomerate’s stock worth $48,574,000 after buying an additional 7,076 shares during the last quarter. Finally, Thrive Wealth Management LLC grew its stake in shares of Danaher by 4.9% during the first quarter. Thrive Wealth Management LLC now owns 6,070 shares of the conglomerate’s stock worth $1,516,000 after buying an additional 283 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

DHR traded down $4.45 on Thursday, hitting $251.55. The company’s stock had a trading volume of 1,212,538 shares, compared to its average volume of 2,727,238. The company’s 50 day simple moving average is $270.43 and its 200-day simple moving average is $260.43. The firm has a market cap of $186.32 billion, a P/E ratio of 42.65, a price-to-earnings-growth ratio of 4.49 and a beta of 0.83. Danaher Co. has a 12 month low of $182.09 and a 12 month high of $281.70. The company has a quick ratio of 1.04, a current ratio of 1.43 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.94% and a return on equity of 11.06%. The company had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same period last year, the firm earned $2.02 EPS. Danaher’s revenue for the quarter was up 3.1% on a year-over-year basis. Analysts forecast that Danaher Co. will post 7.59 EPS for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Friday, September 27th will be paid a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.43%. The ex-dividend date is Friday, September 27th. Danaher’s dividend payout ratio is presently 18.31%.

Wall Street Analyst Weigh In

DHR has been the topic of a number of research reports. Stephens reaffirmed an “overweight” rating and set a $315.00 target price on shares of Danaher in a research note on Wednesday. Evercore ISI boosted their price objective on shares of Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. TD Cowen boosted their price objective on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday. Raymond James dropped their target price on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Wednesday. Finally, Bank of America upped their price objective on shares of Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. Seven investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus target price of $287.28.

Insiders Place Their Bets

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the sale, the senior vice president now directly owns 4,212 shares in the company, valued at $1,130,374.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares in the company, valued at approximately $1,130,374.44. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Rainer Blair sold 9,007 shares of the firm’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $280.00, for a total transaction of $2,521,960.00. Following the sale, the chief executive officer now owns 97,983 shares in the company, valued at approximately $27,435,240. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,059 shares of company stock worth $8,400,897 in the last three months. 11.10% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.